| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Breast Neoplasms | 98 | 2024 | 509 | 16.080 |
Why?
|
| Breast Neoplasms | 168 | 2023 | 15694 | 8.500 |
Why?
|
| Triple Negative Breast Neoplasms | 43 | 2024 | 1215 | 7.080 |
Why?
|
| Receptor, ErbB-2 | 69 | 2023 | 2518 | 5.940 |
Why?
|
| Neoplastic Cells, Circulating | 22 | 2020 | 607 | 3.370 |
Why?
|
| Xenopus laevis | 29 | 2020 | 270 | 3.270 |
Why?
|
| Xenopus Proteins | 32 | 2016 | 185 | 3.000 |
Why?
|
| Bone Neoplasms | 26 | 2020 | 2576 | 2.800 |
Why?
|
| Xenopus | 30 | 2016 | 219 | 2.700 |
Why?
|
| Bone Morphogenetic Proteins | 49 | 2015 | 268 | 2.350 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 61 | 2024 | 15862 | 2.300 |
Why?
|
| Female | 328 | 2024 | 141928 | 2.190 |
Why?
|
| Neoadjuvant Therapy | 36 | 2024 | 4975 | 2.100 |
Why?
|
| Receptors, Estrogen | 28 | 2021 | 2086 | 2.050 |
Why?
|
| Adenovirus E1A Proteins | 11 | 2009 | 163 | 1.960 |
Why?
|
| Humans | 429 | 2024 | 261506 | 1.930 |
Why?
|
| Quinazolines | 9 | 2014 | 923 | 1.860 |
Why?
|
| Biomarkers, Tumor | 49 | 2022 | 10331 | 1.840 |
Why?
|
| Trastuzumab | 22 | 2022 | 696 | 1.790 |
Why?
|
| Neoplasm Metastasis | 46 | 2021 | 5112 | 1.780 |
Why?
|
| Gastrula | 16 | 2013 | 62 | 1.680 |
Why?
|
| Signal Transduction | 71 | 2023 | 11965 | 1.680 |
Why?
|
| Phosphoproteins | 12 | 2014 | 1152 | 1.630 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 18 | 2022 | 1265 | 1.600 |
Why?
|
| Receptors, Growth Factor | 24 | 2002 | 157 | 1.550 |
Why?
|
| ErbB Receptors | 16 | 2022 | 2295 | 1.500 |
Why?
|
| Carcinoma, Ductal, Breast | 13 | 2020 | 1216 | 1.480 |
Why?
|
| Xenograft Model Antitumor Assays | 25 | 2021 | 3821 | 1.480 |
Why?
|
| Embryo, Nonmammalian | 32 | 2019 | 234 | 1.470 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 42 | 2013 | 6550 | 1.460 |
Why?
|
| Apoptosis | 28 | 2020 | 7591 | 1.450 |
Why?
|
| Animals | 193 | 2024 | 59536 | 1.450 |
Why?
|
| Cell Line, Tumor | 63 | 2023 | 14551 | 1.430 |
Why?
|
| Neoplastic Stem Cells | 19 | 2020 | 1443 | 1.430 |
Why?
|
| Middle Aged | 183 | 2023 | 86204 | 1.430 |
Why?
|
| Receptors, Androgen | 6 | 2019 | 878 | 1.420 |
Why?
|
| Antineoplastic Agents | 53 | 2024 | 14289 | 1.400 |
Why?
|
| Genetic Therapy | 11 | 2021 | 1616 | 1.390 |
Why?
|
| Adult | 165 | 2021 | 77950 | 1.380 |
Why?
|
| Cell Proliferation | 29 | 2023 | 7226 | 1.370 |
Why?
|
| Ovarian Neoplasms | 22 | 2020 | 4638 | 1.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 36 | 2022 | 8873 | 1.330 |
Why?
|
| Paclitaxel | 11 | 2024 | 1996 | 1.330 |
Why?
|
| Mesoderm | 19 | 2013 | 404 | 1.310 |
Why?
|
| Prognosis | 75 | 2023 | 21713 | 1.260 |
Why?
|
| Transplantation Conditioning | 23 | 2010 | 2238 | 1.260 |
Why?
|
| Neoplasm Staging | 52 | 2023 | 13658 | 1.240 |
Why?
|
| Aged | 132 | 2021 | 70117 | 1.210 |
Why?
|
| Cadherins | 9 | 2023 | 660 | 1.210 |
Why?
|
| Tumor Microenvironment | 14 | 2022 | 2864 | 1.180 |
Why?
|
| Disease-Free Survival | 50 | 2021 | 10001 | 1.180 |
Why?
|
| Chemotherapy, Adjuvant | 28 | 2023 | 3890 | 1.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 6 | 2019 | 840 | 1.140 |
Why?
|
| Cyclin-Dependent Kinase 2 | 6 | 2017 | 249 | 1.140 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 7 | 2009 | 216 | 1.110 |
Why?
|
| Adenocarcinoma, Clear Cell | 4 | 2011 | 178 | 1.100 |
Why?
|
| Mice | 94 | 2024 | 34495 | 1.100 |
Why?
|
| Molecular Targeted Therapy | 10 | 2021 | 2330 | 1.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 10 | 2021 | 973 | 1.090 |
Why?
|
| Cell Movement | 19 | 2021 | 2466 | 1.080 |
Why?
|
| Body Patterning | 18 | 2011 | 212 | 1.040 |
Why?
|
| Transforming Growth Factor beta | 27 | 2010 | 1130 | 1.040 |
Why?
|
| Embryonic Development | 8 | 2020 | 306 | 1.040 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2021 | 621 | 1.020 |
Why?
|
| Graft vs Tumor Effect | 13 | 2008 | 139 | 1.010 |
Why?
|
| Benzimidazoles | 4 | 2017 | 428 | 0.970 |
Why?
|
| Notochord | 4 | 2013 | 12 | 0.960 |
Why?
|
| RANK Ligand | 3 | 2017 | 119 | 0.940 |
Why?
|
| Cell Polarity | 6 | 2010 | 208 | 0.930 |
Why?
|
| Epithelium | 6 | 2020 | 720 | 0.910 |
Why?
|
| Drug Resistance, Neoplasm | 17 | 2019 | 5178 | 0.910 |
Why?
|
| Gene Expression Regulation, Developmental | 37 | 2014 | 1498 | 0.900 |
Why?
|
| Aged, 80 and over | 60 | 2021 | 29902 | 0.870 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2017 | 2488 | 0.870 |
Why?
|
| Clinical Trials as Topic | 9 | 2022 | 3719 | 0.870 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 6 | 2020 | 301 | 0.860 |
Why?
|
| Inflammation | 10 | 2021 | 2522 | 0.860 |
Why?
|
| Carcinoma | 11 | 2017 | 2578 | 0.860 |
Why?
|
| Trans-Activators | 14 | 2017 | 1555 | 0.860 |
Why?
|
| Morphogenesis | 13 | 2016 | 337 | 0.850 |
Why?
|
| Stathmin | 2 | 2013 | 30 | 0.850 |
Why?
|
| Carrier Proteins | 14 | 2011 | 2022 | 0.850 |
Why?
|
| Proportional Hazards Models | 25 | 2022 | 4988 | 0.850 |
Why?
|
| Transplantation, Homologous | 35 | 2013 | 2843 | 0.850 |
Why?
|
| Antibodies, Monoclonal, Humanized | 16 | 2022 | 3251 | 0.850 |
Why?
|
| Gene Expression Profiling | 29 | 2022 | 5159 | 0.840 |
Why?
|
| Receptors, Progesterone | 18 | 2020 | 1392 | 0.840 |
Why?
|
| Neoplasms | 24 | 2023 | 15193 | 0.830 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2020 | 280 | 0.830 |
Why?
|
| Retrospective Studies | 79 | 2022 | 37905 | 0.820 |
Why?
|
| Kaplan-Meier Estimate | 31 | 2021 | 6207 | 0.820 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2011 | 287 | 0.810 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2012 | 72 | 0.800 |
Why?
|
| Stress, Mechanical | 3 | 2020 | 311 | 0.800 |
Why?
|
| Phosphorylation | 19 | 2020 | 4804 | 0.800 |
Why?
|
| In Situ Hybridization | 32 | 2016 | 1037 | 0.790 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2015 | 488 | 0.790 |
Why?
|
| Mastectomy | 21 | 2021 | 1534 | 0.790 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2019 | 4757 | 0.780 |
Why?
|
| Positron-Emission Tomography | 11 | 2015 | 2173 | 0.780 |
Why?
|
| Transfection | 28 | 2021 | 2944 | 0.780 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2020 | 182 | 0.780 |
Why?
|
| Wnt Signaling Pathway | 6 | 2017 | 430 | 0.780 |
Why?
|
| Epithelial Cell Adhesion Molecule | 2 | 2020 | 35 | 0.770 |
Why?
|
| Treatment Outcome | 56 | 2024 | 32848 | 0.770 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2020 | 1493 | 0.760 |
Why?
|
| Dipeptides | 1 | 2020 | 91 | 0.740 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2019 | 160 | 0.740 |
Why?
|
| Amino Acid Sequence | 46 | 2016 | 4233 | 0.730 |
Why?
|
| Cell Self Renewal | 1 | 2020 | 62 | 0.720 |
Why?
|
| Survival Rate | 43 | 2022 | 12221 | 0.720 |
Why?
|
| Macrophages | 8 | 2020 | 1304 | 0.720 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2009 | 852 | 0.720 |
Why?
|
| Carcinoma, Lobular | 7 | 2020 | 611 | 0.710 |
Why?
|
| Alpha Particles | 1 | 2019 | 26 | 0.710 |
Why?
|
| Cytoplasm | 6 | 2011 | 652 | 0.710 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2020 | 292 | 0.710 |
Why?
|
| Mutation | 31 | 2022 | 15179 | 0.700 |
Why?
|
| Cell Differentiation | 22 | 2020 | 4078 | 0.700 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2018 | 72 | 0.700 |
Why?
|
| Bone and Bones | 6 | 2019 | 619 | 0.700 |
Why?
|
| Molecular Sequence Data | 45 | 2011 | 6089 | 0.690 |
Why?
|
| Sarcopenia | 1 | 2021 | 110 | 0.690 |
Why?
|
| Zebrafish | 8 | 2011 | 463 | 0.690 |
Why?
|
| Benzamides | 4 | 2022 | 1832 | 0.690 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2010 | 460 | 0.680 |
Why?
|
| Aurora Kinase A | 3 | 2023 | 202 | 0.670 |
Why?
|
| Gastrulation | 3 | 2020 | 24 | 0.670 |
Why?
|
| Young Adult | 38 | 2020 | 21445 | 0.670 |
Why?
|
| Mice, Nude | 18 | 2023 | 4307 | 0.660 |
Why?
|
| Oncologists | 1 | 2021 | 134 | 0.660 |
Why?
|
| Lactones | 1 | 2019 | 94 | 0.660 |
Why?
|
| Combined Modality Therapy | 30 | 2021 | 8865 | 0.660 |
Why?
|
| Radium | 1 | 2019 | 93 | 0.660 |
Why?
|
| Oncolytic Virotherapy | 1 | 2021 | 280 | 0.650 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 27 | 0.650 |
Why?
|
| Adaptor Proteins, Signal Transducing | 14 | 2013 | 1439 | 0.640 |
Why?
|
| Biological Products | 1 | 2021 | 274 | 0.640 |
Why?
|
| Drosophila Proteins | 13 | 2011 | 858 | 0.640 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2021 | 992 | 0.630 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 848 | 0.620 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 92 | 0.620 |
Why?
|
| Pyridines | 4 | 2022 | 1244 | 0.620 |
Why?
|
| Caspase 8 | 2 | 2016 | 145 | 0.620 |
Why?
|
| Nomograms | 2 | 2017 | 313 | 0.620 |
Why?
|
| Chemokine CXCL1 | 1 | 2017 | 60 | 0.620 |
Why?
|
| Indazoles | 2 | 2018 | 297 | 0.610 |
Why?
|
| Receptor, EphA2 | 1 | 2018 | 132 | 0.610 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2017 | 46 | 0.610 |
Why?
|
| Tamoxifen | 4 | 2019 | 876 | 0.610 |
Why?
|
| Cell Size | 2 | 2016 | 136 | 0.610 |
Why?
|
| Follow-Up Studies | 37 | 2020 | 14889 | 0.610 |
Why?
|
| Receptor, Notch1 | 2 | 2016 | 218 | 0.600 |
Why?
|
| Bone Morphogenetic Protein 4 | 21 | 2020 | 101 | 0.590 |
Why?
|
| Fluoxymesterone | 1 | 2016 | 9 | 0.590 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 76 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 20 | 2020 | 7551 | 0.580 |
Why?
|
| Genes, erbB-2 | 5 | 2011 | 229 | 0.580 |
Why?
|
| Deoxycytidine | 2 | 2020 | 1353 | 0.580 |
Why?
|
| Cholesterol | 4 | 2018 | 658 | 0.570 |
Why?
|
| Zebrafish Proteins | 8 | 2011 | 163 | 0.570 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2017 | 112 | 0.570 |
Why?
|
| Thrombocytosis | 1 | 2017 | 121 | 0.570 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2016 | 142 | 0.570 |
Why?
|
| Survival Analysis | 27 | 2019 | 9180 | 0.570 |
Why?
|
| Tomography, Emission-Computed | 4 | 2012 | 310 | 0.570 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2016 | 30 | 0.570 |
Why?
|
| Breast | 8 | 2021 | 1344 | 0.550 |
Why?
|
| Gene Expression | 19 | 2017 | 3570 | 0.550 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2007 | 2326 | 0.550 |
Why?
|
| Proteins | 18 | 2009 | 1963 | 0.550 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 778 | 0.540 |
Why?
|
| Blotting, Western | 15 | 2014 | 3536 | 0.540 |
Why?
|
| Fibroblast Growth Factors | 6 | 2011 | 257 | 0.540 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2017 | 275 | 0.540 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 669 | 0.540 |
Why?
|
| RNA, Messenger | 38 | 2013 | 6150 | 0.540 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2015 | 43 | 0.540 |
Why?
|
| Health Education | 1 | 2018 | 309 | 0.530 |
Why?
|
| Vidarabine | 8 | 2008 | 1341 | 0.530 |
Why?
|
| Aurora Kinase B | 1 | 2015 | 68 | 0.530 |
Why?
|
| Immunoconjugates | 4 | 2022 | 279 | 0.520 |
Why?
|
| Tumor Cells, Cultured | 23 | 2020 | 5395 | 0.510 |
Why?
|
| Cyclooxygenase 2 | 5 | 2023 | 483 | 0.510 |
Why?
|
| Indoles | 1 | 2020 | 1009 | 0.510 |
Why?
|
| Dendritic Cells | 2 | 2018 | 1085 | 0.510 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 16 | 2016 | 2508 | 0.510 |
Why?
|
| Immunohistochemistry | 24 | 2022 | 7548 | 0.500 |
Why?
|
| Erlotinib Hydrochloride | 7 | 2015 | 388 | 0.500 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 19 | 2016 | 3639 | 0.500 |
Why?
|
| Albumins | 1 | 2016 | 258 | 0.500 |
Why?
|
| Body Mass Index | 4 | 2018 | 2203 | 0.500 |
Why?
|
| Ovary | 6 | 2012 | 668 | 0.490 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2017 | 1823 | 0.490 |
Why?
|
| Homeodomain Proteins | 12 | 2014 | 1143 | 0.490 |
Why?
|
| Immunoenzyme Techniques | 5 | 2014 | 1165 | 0.480 |
Why?
|
| Neoplasm Recurrence, Local | 20 | 2023 | 10035 | 0.480 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2024 | 521 | 0.480 |
Why?
|
| Social Media | 1 | 2018 | 203 | 0.480 |
Why?
|
| MAP Kinase Kinase Kinases | 6 | 2003 | 190 | 0.470 |
Why?
|
| Cell Adhesion | 3 | 2013 | 1008 | 0.470 |
Why?
|
| Head | 1 | 2015 | 249 | 0.470 |
Why?
|
| Drugs, Investigational | 2 | 2017 | 135 | 0.470 |
Why?
|
| Receptors, Cell Surface | 16 | 2016 | 862 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 12 | 2017 | 4367 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2018 | 2054 | 0.460 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2020 | 2359 | 0.460 |
Why?
|
| Drug Synergism | 6 | 2019 | 1313 | 0.460 |
Why?
|
| Mediator Complex | 1 | 2013 | 69 | 0.460 |
Why?
|
| Carcinogenesis | 4 | 2021 | 1026 | 0.460 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 17 | 0.460 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2013 | 661 | 0.450 |
Why?
|
| Stem Cells | 2 | 2020 | 1213 | 0.450 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 1879 | 0.450 |
Why?
|
| Precision Medicine | 4 | 2019 | 1154 | 0.450 |
Why?
|
| CDC2 Protein Kinase | 3 | 2009 | 176 | 0.450 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 313 | 0.440 |
Why?
|
| Embryo, Mammalian | 4 | 2018 | 741 | 0.440 |
Why?
|
| Bone Marrow Transplantation | 11 | 2006 | 1581 | 0.430 |
Why?
|
| Neoplasm Grading | 10 | 2020 | 1742 | 0.430 |
Why?
|
| Base Sequence | 27 | 2011 | 4917 | 0.420 |
Why?
|
| LIM Domain Proteins | 7 | 2013 | 104 | 0.420 |
Why?
|
| Isoenzymes | 3 | 2013 | 614 | 0.420 |
Why?
|
| RNA, Small Interfering | 8 | 2020 | 2216 | 0.420 |
Why?
|
| Cell Count | 6 | 2020 | 508 | 0.420 |
Why?
|
| Evolution, Molecular | 7 | 2021 | 834 | 0.420 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2010 | 408 | 0.420 |
Why?
|
| Bone Density Conservation Agents | 2 | 2011 | 198 | 0.410 |
Why?
|
| Drug Discovery | 1 | 2015 | 324 | 0.410 |
Why?
|
| Protein Kinase C | 6 | 2019 | 396 | 0.410 |
Why?
|
| Diphosphonates | 2 | 2011 | 262 | 0.410 |
Why?
|
| Leuprolide | 1 | 2012 | 65 | 0.410 |
Why?
|
| Kidney Neoplasms | 5 | 2007 | 3022 | 0.410 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 318 | 0.410 |
Why?
|
| Estrogen Receptor alpha | 4 | 2021 | 701 | 0.400 |
Why?
|
| Luminescence | 1 | 2011 | 44 | 0.400 |
Why?
|
| Prospective Studies | 24 | 2021 | 12873 | 0.400 |
Why?
|
| Radiation Tolerance | 5 | 2016 | 629 | 0.400 |
Why?
|
| Disease Progression | 13 | 2022 | 6682 | 0.400 |
Why?
|
| Ectoderm | 8 | 2011 | 69 | 0.390 |
Why?
|
| Nerve Tissue Proteins | 7 | 2011 | 1491 | 0.390 |
Why?
|
| Caspases | 5 | 2010 | 661 | 0.390 |
Why?
|
| Aromatase Inhibitors | 2 | 2012 | 305 | 0.390 |
Why?
|
| Predictive Value of Tests | 11 | 2018 | 4892 | 0.390 |
Why?
|
| Histone Deacetylase Inhibitors | 4 | 2017 | 612 | 0.390 |
Why?
|
| Phospholipases A | 2 | 2001 | 52 | 0.390 |
Why?
|
| Prostaglandins | 2 | 2001 | 77 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 639 | 0.390 |
Why?
|
| Disaster Planning | 1 | 2011 | 68 | 0.380 |
Why?
|
| Growth Substances | 8 | 1995 | 300 | 0.380 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 1946 | 0.380 |
Why?
|
| Drosophila | 8 | 2007 | 839 | 0.380 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2013 | 1226 | 0.380 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2016 | 849 | 0.380 |
Why?
|
| Neural Tube | 2 | 2010 | 51 | 0.380 |
Why?
|
| Multimodal Imaging | 2 | 2012 | 550 | 0.380 |
Why?
|
| Investigational New Drug Application | 1 | 2010 | 3 | 0.370 |
Why?
|
| MCF-7 Cells | 5 | 2021 | 550 | 0.370 |
Why?
|
| Tumor Burden | 10 | 2021 | 1987 | 0.370 |
Why?
|
| DNA-Binding Proteins | 18 | 2011 | 4821 | 0.370 |
Why?
|
| Hypereosinophilic Syndrome | 3 | 2006 | 89 | 0.370 |
Why?
|
| Total Quality Management | 1 | 2010 | 34 | 0.370 |
Why?
|
| Lymphatic Metastasis | 12 | 2022 | 4844 | 0.370 |
Why?
|
| Neuropeptides | 2 | 2002 | 154 | 0.370 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2001 | 215 | 0.360 |
Why?
|
| Phenotype | 18 | 2021 | 6295 | 0.360 |
Why?
|
| Sequence Homology, Amino Acid | 16 | 2016 | 997 | 0.360 |
Why?
|
| Menopause, Premature | 1 | 2009 | 17 | 0.360 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2021 | 4938 | 0.360 |
Why?
|
| Disasters | 1 | 2011 | 107 | 0.360 |
Why?
|
| Neoplasm Invasiveness | 15 | 2021 | 3981 | 0.360 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2002 | 129 | 0.360 |
Why?
|
| Cytokines | 7 | 2019 | 2809 | 0.360 |
Why?
|
| MicroRNAs | 8 | 2018 | 2947 | 0.360 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 494 | 0.350 |
Why?
|
| Graft vs Host Disease | 21 | 2013 | 2638 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 521 | 0.350 |
Why?
|
| Caenorhabditis elegans | 3 | 2004 | 268 | 0.350 |
Why?
|
| Actins | 4 | 2021 | 608 | 0.350 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2020 | 2232 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2018 | 419 | 0.340 |
Why?
|
| Lung Neoplasms | 10 | 2022 | 11538 | 0.340 |
Why?
|
| Enzyme Activation | 6 | 2016 | 1764 | 0.340 |
Why?
|
| Blastocyst | 1 | 2009 | 124 | 0.340 |
Why?
|
| Cloning, Molecular | 21 | 2005 | 1213 | 0.340 |
Why?
|
| Protein Binding | 12 | 2016 | 3438 | 0.340 |
Why?
|
| Cell Cycle | 9 | 2018 | 2084 | 0.340 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 244 | 0.340 |
Why?
|
| Autophagy | 4 | 2021 | 927 | 0.340 |
Why?
|
| Oligonucleotides, Antisense | 7 | 2011 | 248 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2015 | 641 | 0.340 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2017 | 986 | 0.330 |
Why?
|
| Drug Approval | 1 | 2010 | 178 | 0.330 |
Why?
|
| Glycoproteins | 8 | 2009 | 747 | 0.330 |
Why?
|
| Repressor Proteins | 7 | 2011 | 1664 | 0.330 |
Why?
|
| World Health Organization | 1 | 2010 | 316 | 0.330 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 3869 | 0.320 |
Why?
|
| Immunotherapy | 5 | 2022 | 3341 | 0.320 |
Why?
|
| Infertility | 2 | 2008 | 123 | 0.320 |
Why?
|
| Amenorrhea | 1 | 2008 | 34 | 0.320 |
Why?
|
| Cisplatin | 6 | 2020 | 2432 | 0.320 |
Why?
|
| Gonads | 1 | 2008 | 53 | 0.320 |
Why?
|
| Vimentin | 2 | 2020 | 253 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 577 | 0.320 |
Why?
|
| Biomechanical Phenomena | 5 | 2020 | 338 | 0.310 |
Why?
|
| Mechanical Phenomena | 2 | 2019 | 30 | 0.310 |
Why?
|
| Transplantation Chimera | 4 | 2008 | 155 | 0.310 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2023 | 1546 | 0.310 |
Why?
|
| Japan | 4 | 2019 | 227 | 0.310 |
Why?
|
| Infertility, Female | 1 | 2009 | 217 | 0.310 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2024 | 1678 | 0.310 |
Why?
|
| Membrane Proteins | 11 | 2017 | 2819 | 0.310 |
Why?
|
| Azoospermia | 1 | 2008 | 45 | 0.310 |
Why?
|
| Time Factors | 19 | 2018 | 12926 | 0.310 |
Why?
|
| Cancer Care Facilities | 3 | 2017 | 884 | 0.300 |
Why?
|
| Pyrimidines | 4 | 2024 | 3518 | 0.300 |
Why?
|
| Wnt Proteins | 9 | 2017 | 397 | 0.300 |
Why?
|
| Down-Regulation | 11 | 2020 | 2074 | 0.300 |
Why?
|
| Fertility | 2 | 2008 | 336 | 0.300 |
Why?
|
| Transcription Factors | 14 | 2011 | 5270 | 0.300 |
Why?
|
| Cell Line | 18 | 2018 | 5114 | 0.290 |
Why?
|
| Patient-Centered Care | 1 | 2010 | 294 | 0.290 |
Why?
|
| Multivariate Analysis | 13 | 2017 | 4298 | 0.290 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 2138 | 0.290 |
Why?
|
| Mice, SCID | 10 | 2022 | 1869 | 0.290 |
Why?
|
| Radiopharmaceuticals | 7 | 2020 | 1301 | 0.290 |
Why?
|
| Myeloablative Agonists | 5 | 2009 | 384 | 0.290 |
Why?
|
| Pyrazoles | 2 | 2024 | 1471 | 0.290 |
Why?
|
| Piperazines | 1 | 2015 | 2101 | 0.280 |
Why?
|
| Calcium | 3 | 2011 | 1537 | 0.280 |
Why?
|
| Radiation-Sensitizing Agents | 3 | 2014 | 363 | 0.280 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2001 | 1064 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 9 | 2017 | 3101 | 0.280 |
Why?
|
| Liver Neoplasms | 7 | 2020 | 4557 | 0.280 |
Why?
|
| Dinoprostone | 2 | 2023 | 208 | 0.280 |
Why?
|
| Insect Proteins | 5 | 2000 | 91 | 0.270 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 200 | 0.270 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2005 | 22 | 0.270 |
Why?
|
| GTPase-Activating Proteins | 1 | 2006 | 126 | 0.270 |
Why?
|
| Recombinant Proteins | 15 | 2020 | 2927 | 0.270 |
Why?
|
| Anthracyclines | 4 | 2015 | 331 | 0.270 |
Why?
|
| Taxoids | 5 | 2018 | 967 | 0.270 |
Why?
|
| Thionucleotides | 1 | 2005 | 65 | 0.270 |
Why?
|
| Transcriptome | 4 | 2022 | 1859 | 0.270 |
Why?
|
| Radioisotopes | 2 | 2019 | 177 | 0.270 |
Why?
|
| Stem Cell Transplantation | 6 | 2012 | 1360 | 0.270 |
Why?
|
| Cyclin A | 1 | 2005 | 47 | 0.270 |
Why?
|
| DNA, Complementary | 12 | 2007 | 869 | 0.270 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2005 | 31 | 0.270 |
Why?
|
| Denosumab | 2 | 2019 | 68 | 0.270 |
Why?
|
| Recurrence | 11 | 2018 | 4758 | 0.270 |
Why?
|
| Antineoplastic Agents, Immunological | 3 | 2022 | 1249 | 0.270 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2016 | 311 | 0.270 |
Why?
|
| Obesity | 6 | 2021 | 2884 | 0.260 |
Why?
|
| Interleukin-6 | 3 | 2024 | 1038 | 0.260 |
Why?
|
| Tail | 4 | 2008 | 28 | 0.260 |
Why?
|
| Male | 81 | 2021 | 123000 | 0.260 |
Why?
|
| DNA Primers | 10 | 2010 | 1399 | 0.260 |
Why?
|
| Fatty Acid Desaturases | 1 | 2004 | 14 | 0.260 |
Why?
|
| Lipoproteins, HDL | 2 | 2016 | 144 | 0.260 |
Why?
|
| Adipose Tissue, Brown | 2 | 1997 | 112 | 0.260 |
Why?
|
| Transcription, Genetic | 9 | 2017 | 3154 | 0.260 |
Why?
|
| Copper | 2 | 2015 | 165 | 0.260 |
Why?
|
| Cohort Studies | 14 | 2021 | 9244 | 0.260 |
Why?
|
| Spheroids, Cellular | 7 | 2014 | 222 | 0.250 |
Why?
|
| Melphalan | 7 | 2008 | 834 | 0.250 |
Why?
|
| Patient Care Team | 1 | 2010 | 795 | 0.250 |
Why?
|
| Brain Neoplasms | 7 | 2022 | 4849 | 0.250 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 748 | 0.250 |
Why?
|
| Simvastatin | 2 | 2015 | 106 | 0.250 |
Why?
|
| Ciona intestinalis | 3 | 2011 | 4 | 0.250 |
Why?
|
| Up-Regulation | 10 | 2019 | 2450 | 0.250 |
Why?
|
| Endophenotypes | 1 | 2024 | 18 | 0.240 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 423 | 0.240 |
Why?
|
| Arabidopsis Proteins | 1 | 2004 | 82 | 0.240 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 278 | 0.240 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2020 | 833 | 0.240 |
Why?
|
| Cell Nucleus | 4 | 2018 | 1620 | 0.240 |
Why?
|
| Sulfonamides | 2 | 2018 | 1823 | 0.240 |
Why?
|
| Cell Dedifferentiation | 2 | 2016 | 96 | 0.240 |
Why?
|
| Spindle Apparatus | 1 | 2004 | 93 | 0.240 |
Why?
|
| Cyclophosphamide | 8 | 2015 | 3001 | 0.240 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2003 | 54 | 0.240 |
Why?
|
| Medical Oncology | 2 | 2010 | 1423 | 0.240 |
Why?
|
| Survivors | 1 | 2009 | 1031 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Color | 4 | 1998 | 100 | 0.230 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1960 | 0.230 |
Why?
|
| Pilot Projects | 7 | 2015 | 2803 | 0.230 |
Why?
|
| HeLa Cells | 5 | 2016 | 1643 | 0.230 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2021 | 566 | 0.230 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 3552 | 0.230 |
Why?
|
| Biomarkers | 8 | 2021 | 5047 | 0.220 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 1997 | 21 | 0.220 |
Why?
|
| Genetic Vectors | 8 | 2014 | 1694 | 0.220 |
Why?
|
| Fluorouracil | 5 | 2015 | 1944 | 0.220 |
Why?
|
| Genome, Human | 4 | 2021 | 1869 | 0.220 |
Why?
|
| Adenoviruses, Human | 2 | 2000 | 181 | 0.220 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 96 | 0.220 |
Why?
|
| Immunosuppressive Agents | 8 | 2009 | 1375 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 6 | 2017 | 2314 | 0.210 |
Why?
|
| Cell Communication | 3 | 2018 | 509 | 0.210 |
Why?
|
| Cerebral Arteries | 3 | 1997 | 73 | 0.210 |
Why?
|
| Ecosystem | 1 | 2023 | 111 | 0.210 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2012 | 44 | 0.210 |
Why?
|
| Hematoma | 1 | 2003 | 160 | 0.210 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2022 | 51 | 0.210 |
Why?
|
| Nervous System | 4 | 2002 | 165 | 0.210 |
Why?
|
| Multigene Family | 3 | 2016 | 425 | 0.210 |
Why?
|
| Breast Cancer Lymphedema | 1 | 2022 | 38 | 0.210 |
Why?
|
| Quality of Health Care | 2 | 2017 | 621 | 0.210 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 2283 | 0.210 |
Why?
|
| Patient Participation | 2 | 2016 | 446 | 0.210 |
Why?
|
| Axilla | 6 | 2022 | 902 | 0.210 |
Why?
|
| ATP Binding Cassette Transporter 1 | 2 | 2018 | 29 | 0.210 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 11 | 2002 | 74 | 0.200 |
Why?
|
| Radiotherapy, Adjuvant | 8 | 2015 | 2231 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2018 | 1217 | 0.200 |
Why?
|
| DNA Copy Number Variations | 5 | 2022 | 1516 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2020 | 198 | 0.200 |
Why?
|
| Decorin | 1 | 2021 | 13 | 0.200 |
Why?
|
| RNA Interference | 3 | 2016 | 1408 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 3 | 2014 | 1547 | 0.200 |
Why?
|
| Receptors, Fibroblast Growth Factor | 6 | 2007 | 153 | 0.200 |
Why?
|
| Herpesvirus 1, Human | 1 | 2021 | 113 | 0.200 |
Why?
|
| Remission Induction | 8 | 2017 | 3569 | 0.200 |
Why?
|
| Gallbladder | 1 | 2001 | 69 | 0.190 |
Why?
|
| Blotting, Northern | 8 | 2005 | 682 | 0.190 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2018 | 245 | 0.190 |
Why?
|
| Hodgkin Disease | 5 | 2012 | 1429 | 0.190 |
Why?
|
| Folate Receptor 1 | 1 | 2021 | 62 | 0.190 |
Why?
|
| Risk Factors | 21 | 2018 | 17523 | 0.190 |
Why?
|
| Phospholipase D | 1 | 2000 | 26 | 0.190 |
Why?
|
| Transplantation, Autologous | 11 | 2013 | 1914 | 0.190 |
Why?
|
| Organophosphorus Compounds | 2 | 2012 | 101 | 0.190 |
Why?
|
| Fitness Trackers | 1 | 2020 | 22 | 0.190 |
Why?
|
| Tetraspanin 24 | 1 | 2020 | 5 | 0.190 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 1997 | 15 | 0.190 |
Why?
|
| Cell Survival | 8 | 2021 | 3045 | 0.190 |
Why?
|
| Sequence Alignment | 6 | 2016 | 844 | 0.190 |
Why?
|
| Acceleration | 1 | 2020 | 32 | 0.190 |
Why?
|
| Osteoblasts | 6 | 2010 | 370 | 0.190 |
Why?
|
| Receptor, Notch4 | 1 | 2020 | 13 | 0.190 |
Why?
|
| Forkhead Box Protein O3 | 3 | 2015 | 113 | 0.190 |
Why?
|
| Dishevelled Proteins | 4 | 2003 | 59 | 0.190 |
Why?
|
| Cladribine | 2 | 2001 | 233 | 0.190 |
Why?
|
| Hematologic Neoplasms | 4 | 2008 | 1870 | 0.190 |
Why?
|
| Central Nervous System | 3 | 2011 | 436 | 0.180 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2001 | 133 | 0.180 |
Why?
|
| Bridged-Ring Compounds | 3 | 2015 | 183 | 0.180 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 486 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2017 | 371 | 0.180 |
Why?
|
| Models, Biological | 8 | 2016 | 3254 | 0.180 |
Why?
|
| Vitreous Body | 3 | 1997 | 123 | 0.180 |
Why?
|
| Genes, Helminth | 1 | 1999 | 25 | 0.180 |
Why?
|
| Antigens, Neoplasm | 6 | 2020 | 1506 | 0.180 |
Why?
|
| Smad7 Protein | 1 | 2020 | 16 | 0.180 |
Why?
|
| Estrogen Receptor beta | 1 | 2021 | 155 | 0.180 |
Why?
|
| Genetic Testing | 3 | 2018 | 1589 | 0.180 |
Why?
|
| Movement | 3 | 2018 | 556 | 0.180 |
Why?
|
| Intercellular Junctions | 1 | 2020 | 54 | 0.180 |
Why?
|
| Egg Proteins, Dietary | 1 | 1999 | 4 | 0.180 |
Why?
|
| G1 Phase | 3 | 2011 | 285 | 0.180 |
Why?
|
| Postmenopause | 2 | 2019 | 378 | 0.180 |
Why?
|
| Flow Cytometry | 4 | 2013 | 3033 | 0.180 |
Why?
|
| Bone Morphogenetic Protein 2 | 10 | 2001 | 142 | 0.180 |
Why?
|
| Valproic Acid | 2 | 2012 | 263 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2019 | 43 | 0.180 |
Why?
|
| Protein Array Analysis | 2 | 2014 | 501 | 0.180 |
Why?
|
| Cluster Analysis | 4 | 2019 | 1053 | 0.180 |
Why?
|
| Neurons | 7 | 2014 | 2287 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2022 | 224 | 0.180 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 94 | 0.170 |
Why?
|
| Adolescent | 20 | 2017 | 31252 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2020 | 259 | 0.170 |
Why?
|
| Gene Frequency | 3 | 2017 | 1163 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2018 | 850 | 0.170 |
Why?
|
| Serpins | 1 | 1999 | 77 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 591 | 0.170 |
Why?
|
| Radiation Injuries | 2 | 2006 | 1411 | 0.170 |
Why?
|
| Microfilament Proteins | 2 | 2010 | 487 | 0.170 |
Why?
|
| Interleukin-2 | 2 | 2009 | 842 | 0.170 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2018 | 104 | 0.170 |
Why?
|
| Bile Ducts, Extrahepatic | 5 | 1996 | 38 | 0.170 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 338 | 0.170 |
Why?
|
| Nitriles | 1 | 2024 | 906 | 0.170 |
Why?
|
| Lymphedema | 1 | 2022 | 239 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 266 | 0.170 |
Why?
|
| Gene Expression Regulation | 6 | 2008 | 4053 | 0.170 |
Why?
|
| Smad3 Protein | 1 | 2020 | 129 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 169 | 0.170 |
Why?
|
| Regeneration | 3 | 2008 | 279 | 0.170 |
Why?
|
| Mechanoreceptors | 1 | 1998 | 28 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 333 | 0.170 |
Why?
|
| Heterografts | 2 | 2019 | 733 | 0.170 |
Why?
|
| Sialyltransferases | 1 | 2018 | 23 | 0.170 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 573 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 5 | 2016 | 1077 | 0.170 |
Why?
|
| Genes, Viral | 1 | 1999 | 202 | 0.170 |
Why?
|
| Bone Morphogenetic Protein Receptors | 12 | 1999 | 32 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 6942 | 0.170 |
Why?
|
| Cell Nucleus Division | 1 | 2018 | 3 | 0.160 |
Why?
|
| Picolinic Acids | 1 | 2018 | 16 | 0.160 |
Why?
|
| Neuroepithelial Cells | 1 | 2018 | 13 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 7 | 2009 | 1487 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2013 | 1555 | 0.160 |
Why?
|
| Markov Chains | 1 | 2019 | 175 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 582 | 0.160 |
Why?
|
| Genes, BRCA2 | 2 | 2017 | 309 | 0.160 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 79 | 0.160 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2018 | 142 | 0.160 |
Why?
|
| Protein Transport | 4 | 2016 | 734 | 0.160 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 7222 | 0.160 |
Why?
|
| Leukopenia | 1 | 2018 | 151 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2017 | 636 | 0.160 |
Why?
|
| Liver Diseases | 1 | 2003 | 574 | 0.160 |
Why?
|
| Fetal Proteins | 4 | 2011 | 28 | 0.160 |
Why?
|
| Portal Vein | 2 | 1997 | 355 | 0.160 |
Why?
|
| COS Cells | 3 | 2016 | 377 | 0.160 |
Why?
|
| Benzothiazoles | 1 | 2018 | 94 | 0.160 |
Why?
|
| Metastasectomy | 1 | 2020 | 200 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2018 | 1549 | 0.160 |
Why?
|
| Alopecia | 1 | 2018 | 126 | 0.160 |
Why?
|
| Genes, BRCA1 | 2 | 2017 | 387 | 0.160 |
Why?
|
| Age Factors | 6 | 2018 | 5377 | 0.160 |
Why?
|
| Thiotepa | 4 | 2006 | 118 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 479 | 0.160 |
Why?
|
| Logistic Models | 4 | 2017 | 3441 | 0.150 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 358 | 0.150 |
Why?
|
| Biopsy | 4 | 2014 | 3443 | 0.150 |
Why?
|
| Body Composition | 1 | 2021 | 595 | 0.150 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2018 | 502 | 0.150 |
Why?
|
| Neural Crest | 5 | 2014 | 85 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 229 | 0.150 |
Why?
|
| Bile Duct Neoplasms | 7 | 1998 | 493 | 0.150 |
Why?
|
| Weight Gain | 2 | 2018 | 464 | 0.150 |
Why?
|
| Mast Cells | 1 | 2019 | 223 | 0.150 |
Why?
|
| Phylogeny | 5 | 2011 | 826 | 0.150 |
Why?
|
| Molecular Weight | 7 | 1999 | 629 | 0.150 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2017 | 26 | 0.150 |
Why?
|
| Microscopy, Confocal | 4 | 2009 | 663 | 0.150 |
Why?
|
| Carmustine | 4 | 2006 | 214 | 0.150 |
Why?
|
| Biocatalysis | 1 | 2017 | 63 | 0.150 |
Why?
|
| Guanosine Diphosphate | 1 | 1997 | 27 | 0.150 |
Why?
|
| Protein Biosynthesis | 5 | 2012 | 889 | 0.150 |
Why?
|
| T-Box Domain Proteins | 4 | 2011 | 156 | 0.150 |
Why?
|
| Biological Transport | 1 | 2018 | 597 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 668 | 0.150 |
Why?
|
| Janus Kinases | 1 | 2018 | 174 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1681 | 0.150 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 2315 | 0.150 |
Why?
|
| Models, Genetic | 4 | 2018 | 1113 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2018 | 2594 | 0.150 |
Why?
|
| U937 Cells | 1 | 2017 | 171 | 0.150 |
Why?
|
| Pneumonia | 1 | 2003 | 751 | 0.150 |
Why?
|
| Drug Interactions | 1 | 2018 | 553 | 0.150 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2018 | 107 | 0.150 |
Why?
|
| Altitude | 1 | 1997 | 39 | 0.150 |
Why?
|
| Interferon-beta | 1 | 2017 | 102 | 0.150 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 430 | 0.150 |
Why?
|
| Polyploidy | 2 | 2011 | 73 | 0.150 |
Why?
|
| Smad4 Protein | 4 | 2020 | 196 | 0.150 |
Why?
|
| Vascular Neoplasms | 1 | 1997 | 114 | 0.140 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2017 | 69 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2016 | 23 | 0.140 |
Why?
|
| Prevalence | 4 | 2021 | 3260 | 0.140 |
Why?
|
| Genes, Dominant | 4 | 2007 | 331 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 216 | 0.140 |
Why?
|
| Receptors, Cytokine | 1 | 1997 | 176 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 181 | 0.140 |
Why?
|
| Teratoma | 1 | 1998 | 236 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 134 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 503 | 0.140 |
Why?
|
| Body Weight | 2 | 2018 | 1293 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 1162 | 0.140 |
Why?
|
| Health Services | 1 | 2017 | 105 | 0.140 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2014 | 160 | 0.140 |
Why?
|
| Protein Kinases | 3 | 2010 | 874 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2016 | 128 | 0.140 |
Why?
|
| Survival | 2 | 2010 | 177 | 0.140 |
Why?
|
| Imidazoles | 3 | 2011 | 999 | 0.140 |
Why?
|
| Somites | 2 | 2010 | 24 | 0.140 |
Why?
|
| Neoplasm Proteins | 6 | 2016 | 3230 | 0.140 |
Why?
|
| Centromere | 1 | 2015 | 97 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2007 | 5437 | 0.130 |
Why?
|
| Plasmids | 5 | 2006 | 837 | 0.130 |
Why?
|
| Prescription Fees | 1 | 2015 | 17 | 0.130 |
Why?
|
| Rats | 15 | 2013 | 6086 | 0.130 |
Why?
|
| Hydrazines | 1 | 2017 | 208 | 0.130 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 119 | 0.130 |
Why?
|
| Platinum Compounds | 1 | 2015 | 131 | 0.130 |
Why?
|
| Spermatogonia | 1 | 2017 | 155 | 0.130 |
Why?
|
| Peptide Fragments | 5 | 2016 | 1271 | 0.130 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2018 | 923 | 0.130 |
Why?
|
| Embryonic Induction | 5 | 1999 | 54 | 0.130 |
Why?
|
| Larva | 6 | 2008 | 274 | 0.130 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 7789 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2013 | 5710 | 0.130 |
Why?
|
| Niacinamide | 1 | 2017 | 421 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2016 | 549 | 0.130 |
Why?
|
| Toxoplasma | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ionophores | 1 | 2015 | 22 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 280 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 256 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 810 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 79 | 0.130 |
Why?
|
| Transgenes | 3 | 2014 | 557 | 0.130 |
Why?
|
| Radiotherapy | 3 | 2017 | 1824 | 0.130 |
Why?
|
| Lipoproteins, VLDL | 1 | 2015 | 89 | 0.130 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 28 | 0.130 |
Why?
|
| Overweight | 1 | 2019 | 484 | 0.130 |
Why?
|
| Norepinephrine | 4 | 1997 | 272 | 0.130 |
Why?
|
| Patient Advocacy | 1 | 2015 | 92 | 0.130 |
Why?
|
| Oncogene Proteins | 1 | 2017 | 354 | 0.130 |
Why?
|
| Proteome | 1 | 2019 | 561 | 0.130 |
Why?
|
| Metamorphosis, Biological | 2 | 2007 | 10 | 0.130 |
Why?
|
| Mastectomy, Segmental | 2 | 2018 | 1026 | 0.130 |
Why?
|
| Standard of Care | 1 | 2016 | 243 | 0.130 |
Why?
|
| Disulfiram | 1 | 2015 | 38 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 502 | 0.130 |
Why?
|
| B7-H1 Antigen | 2 | 2021 | 1022 | 0.130 |
Why?
|
| Genotype | 4 | 2019 | 4109 | 0.130 |
Why?
|
| Cyclin E | 1 | 2017 | 267 | 0.130 |
Why?
|
| Metformin | 1 | 2019 | 378 | 0.130 |
Why?
|
| Celecoxib | 2 | 2023 | 200 | 0.130 |
Why?
|
| Sentinel Lymph Node | 1 | 2017 | 216 | 0.130 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 68 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 360 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 375 | 0.120 |
Why?
|
| Thymosin | 1 | 1994 | 29 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 221 | 0.120 |
Why?
|
| Proteomics | 1 | 2022 | 1380 | 0.120 |
Why?
|
| Algorithms | 6 | 2018 | 3890 | 0.120 |
Why?
|
| Patient Satisfaction | 2 | 2010 | 915 | 0.120 |
Why?
|
| Receptors, Prolactin | 1 | 2014 | 27 | 0.120 |
Why?
|
| Synapsins | 1 | 2013 | 7 | 0.120 |
Why?
|
| DNA Repair | 2 | 2020 | 1872 | 0.120 |
Why?
|
| Leukocyte Transfusion | 2 | 2012 | 43 | 0.120 |
Why?
|
| Interferon Type I | 1 | 1995 | 250 | 0.120 |
Why?
|
| Endosonography | 4 | 1998 | 536 | 0.120 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2013 | 13 | 0.120 |
Why?
|
| Drug Costs | 1 | 2015 | 144 | 0.120 |
Why?
|
| Pyrvinium Compounds | 1 | 2013 | 7 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 470 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 1999 | 568 | 0.120 |
Why?
|
| Prolactin | 1 | 2014 | 155 | 0.120 |
Why?
|
| Exosomes | 1 | 2016 | 253 | 0.120 |
Why?
|
| Doxorubicin | 5 | 2017 | 3005 | 0.120 |
Why?
|
| Phagosomes | 1 | 2013 | 72 | 0.120 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2013 | 8 | 0.120 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 91 | 0.120 |
Why?
|
| Embryonic and Fetal Development | 5 | 1999 | 205 | 0.120 |
Why?
|
| Vertebrates | 2 | 2011 | 68 | 0.120 |
Why?
|
| Cells, Cultured | 11 | 2021 | 5637 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 4 | 1999 | 429 | 0.120 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 194 | 0.120 |
Why?
|
| Cell Division | 6 | 2004 | 2489 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2020 | 1011 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1270 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2017 | 1415 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2017 | 1090 | 0.110 |
Why?
|
| Whole-Body Irradiation | 3 | 2009 | 307 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 2403 | 0.110 |
Why?
|
| Genes, Neoplasm | 2 | 2012 | 324 | 0.110 |
Why?
|
| United States | 8 | 2017 | 15433 | 0.110 |
Why?
|
| Triazoles | 1 | 2017 | 617 | 0.110 |
Why?
|
| Reproducibility of Results | 5 | 2013 | 6009 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2014 | 278 | 0.110 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 141 | 0.110 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2012 | 33 | 0.110 |
Why?
|
| Mesencephalon | 2 | 2005 | 58 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2017 | 731 | 0.110 |
Why?
|
| Samarium | 1 | 2012 | 8 | 0.110 |
Why?
|
| Follistatin | 5 | 2000 | 55 | 0.110 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2012 | 31 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 1084 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 1062 | 0.110 |
Why?
|
| Cell Cycle Proteins | 5 | 2022 | 2045 | 0.110 |
Why?
|
| Genomics | 6 | 2023 | 2738 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2018 | 1048 | 0.100 |
Why?
|
| Fatigue | 1 | 2018 | 1239 | 0.100 |
Why?
|
| Fear | 2 | 2013 | 254 | 0.100 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2011 | 44 | 0.100 |
Why?
|
| Chromosome Mapping | 3 | 2010 | 1471 | 0.100 |
Why?
|
| Microtubules | 1 | 2013 | 270 | 0.100 |
Why?
|
| Piperidines | 1 | 2017 | 1035 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2005 | 6915 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 4 | 2003 | 492 | 0.100 |
Why?
|
| Dendrites | 1 | 2013 | 196 | 0.100 |
Why?
|
| src-Family Kinases | 2 | 2014 | 478 | 0.100 |
Why?
|
| Phosphotyrosine | 2 | 2011 | 111 | 0.100 |
Why?
|
| Point Mutation | 2 | 2013 | 769 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2020 | 7702 | 0.100 |
Why?
|
| Risk Assessment | 7 | 2018 | 6869 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 448 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2004 | 1039 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2003 | 1763 | 0.100 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2012 | 86 | 0.100 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 149 | 0.100 |
Why?
|
| Cathepsin K | 1 | 2010 | 15 | 0.100 |
Why?
|
| Chemoreceptor Cells | 1 | 2010 | 16 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 130 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2001 | 2027 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 158 | 0.100 |
Why?
|
| Smad Proteins | 3 | 2001 | 88 | 0.100 |
Why?
|
| Incidence | 8 | 2018 | 5673 | 0.100 |
Why?
|
| Quality of Life | 2 | 2019 | 4532 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 342 | 0.100 |
Why?
|
| Pyrroles | 2 | 2005 | 576 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 476 | 0.090 |
Why?
|
| Ligands | 3 | 2010 | 995 | 0.090 |
Why?
|
| Women's Health | 1 | 2012 | 205 | 0.090 |
Why?
|
| Genes, erbB-1 | 1 | 2010 | 101 | 0.090 |
Why?
|
| Cell Separation | 1 | 2012 | 612 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 2291 | 0.090 |
Why?
|
| Nectins | 1 | 2010 | 11 | 0.090 |
Why?
|
| Granuloma | 1 | 2012 | 154 | 0.090 |
Why?
|
| Telomerase | 2 | 2014 | 525 | 0.090 |
Why?
|
| Thyroid Neoplasms | 2 | 1998 | 1866 | 0.090 |
Why?
|
| Concept Formation | 1 | 2010 | 32 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2003 | 206 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 28 | 0.090 |
Why?
|
| Patient Selection | 3 | 2015 | 2055 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 598 | 0.090 |
Why?
|
| Muscles | 2 | 2004 | 416 | 0.090 |
Why?
|
| Wnt-5a Protein | 3 | 2008 | 45 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 1993 | 408 | 0.090 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 372 | 0.090 |
Why?
|
| Thiazoles | 1 | 2014 | 726 | 0.090 |
Why?
|
| Myoblasts | 1 | 2010 | 72 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 660 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2012 | 199 | 0.090 |
Why?
|
| Mortality | 2 | 2014 | 343 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 249 | 0.090 |
Why?
|
| Models, Organizational | 1 | 2010 | 76 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 335 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 4 | 2005 | 2979 | 0.090 |
Why?
|
| Monocytes | 3 | 2019 | 788 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 131 | 0.090 |
Why?
|
| Conserved Sequence | 3 | 2009 | 469 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 362 | 0.090 |
Why?
|
| Epidermis | 3 | 2007 | 188 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2011 | 421 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 1586 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2017 | 2292 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 196 | 0.090 |
Why?
|
| Cell Death | 2 | 2014 | 671 | 0.090 |
Why?
|
| Tissue Distribution | 6 | 2007 | 875 | 0.090 |
Why?
|
| Organ Specificity | 5 | 2005 | 699 | 0.090 |
Why?
|
| Palliative Care | 1 | 2021 | 2037 | 0.090 |
Why?
|
| Tissue Array Analysis | 3 | 2018 | 760 | 0.090 |
Why?
|
| Limb Buds | 2 | 2001 | 34 | 0.090 |
Why?
|
| Lymphangiogenesis | 1 | 2009 | 46 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2010 | 266 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 117 | 0.090 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 698 | 0.090 |
Why?
|
| Serine | 1 | 2010 | 388 | 0.090 |
Why?
|
| Radiography | 3 | 2011 | 1904 | 0.080 |
Why?
|
| Minerals | 1 | 1989 | 71 | 0.080 |
Why?
|
| Community Health Services | 1 | 2010 | 126 | 0.080 |
Why?
|
| Histocompatibility Testing | 3 | 1999 | 447 | 0.080 |
Why?
|
| Attitude to Death | 1 | 2009 | 100 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2012 | 1529 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 5539 | 0.080 |
Why?
|
| HCT116 Cells | 1 | 2009 | 348 | 0.080 |
Why?
|
| Caspase 10 | 2 | 2006 | 21 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2010 | 445 | 0.080 |
Why?
|
| Activins | 3 | 2007 | 98 | 0.080 |
Why?
|
| Texas | 4 | 2014 | 6311 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2015 | 1129 | 0.080 |
Why?
|
| Mutagenesis | 4 | 2017 | 483 | 0.080 |
Why?
|
| Menopause | 1 | 1989 | 159 | 0.080 |
Why?
|
| Flax | 1 | 2008 | 3 | 0.080 |
Why?
|
| Esophagogastric Junction | 1 | 2012 | 543 | 0.080 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 931 | 0.080 |
Why?
|
| Mastitis | 1 | 2008 | 12 | 0.080 |
Why?
|
| Lignans | 1 | 2008 | 15 | 0.080 |
Why?
|
| Stomach Neoplasms | 3 | 1999 | 2278 | 0.080 |
Why?
|
| Tacrolimus | 2 | 2000 | 335 | 0.080 |
Why?
|
| DNA, Neoplasm | 2 | 2016 | 1910 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 694 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2003 | 329 | 0.080 |
Why?
|
| Drug Administration Schedule | 3 | 2011 | 3472 | 0.080 |
Why?
|
| Blood Component Removal | 2 | 2006 | 121 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2009 | 267 | 0.080 |
Why?
|
| Cholelithiasis | 2 | 1999 | 43 | 0.080 |
Why?
|
| ROC Curve | 1 | 2011 | 1183 | 0.080 |
Why?
|
| Binding Sites | 7 | 2013 | 2171 | 0.080 |
Why?
|
| Ovariectomy | 1 | 1989 | 330 | 0.080 |
Why?
|
| DNA | 6 | 2006 | 2693 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2007 | 58 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2013 | 1152 | 0.080 |
Why?
|
| Alleles | 5 | 2016 | 2437 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2010 | 321 | 0.080 |
Why?
|
| Tissue Donors | 3 | 2008 | 769 | 0.080 |
Why?
|
| Peptides | 5 | 2009 | 1479 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 837 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 677 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2012 | 712 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2010 | 348 | 0.080 |
Why?
|
| SEER Program | 3 | 2018 | 1000 | 0.080 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 1323 | 0.070 |
Why?
|
| Dinoprost | 1 | 2007 | 33 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1331 | 0.070 |
Why?
|
| Social Support | 1 | 2010 | 560 | 0.070 |
Why?
|
| Androstadienes | 2 | 2019 | 165 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2015 | 780 | 0.070 |
Why?
|
| Hippocampus | 1 | 2013 | 915 | 0.070 |
Why?
|
| Adiponectin | 1 | 2008 | 163 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2013 | 686 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2001 | 4971 | 0.070 |
Why?
|
| Cilia | 1 | 2007 | 92 | 0.070 |
Why?
|
| Clinical Trials, Phase I as Topic | 2 | 2001 | 604 | 0.070 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 1986 | 18 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 37 | 0.070 |
Why?
|
| Frizzled Receptors | 2 | 2003 | 25 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2006 | 43 | 0.070 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2006 | 42 | 0.070 |
Why?
|
| Mucous Membrane | 1 | 2007 | 271 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2007 | 196 | 0.070 |
Why?
|
| Spinal Cord | 3 | 2004 | 690 | 0.070 |
Why?
|
| Strongyloidiasis | 1 | 2006 | 24 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2007 | 128 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2012 | 717 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 3 | 2001 | 5061 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 2022 | 3203 | 0.070 |
Why?
|
| Alkaline Phosphatase | 5 | 1997 | 207 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2009 | 465 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2021 | 515 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2008 | 339 | 0.070 |
Why?
|
| Kidney | 4 | 2010 | 2146 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 342 | 0.070 |
Why?
|
| Chromatin | 2 | 2009 | 942 | 0.070 |
Why?
|
| MSX1 Transcription Factor | 3 | 2000 | 15 | 0.070 |
Why?
|
| Eye | 2 | 2015 | 301 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 260 | 0.070 |
Why?
|
| Esophageal Neoplasms | 2 | 2012 | 3168 | 0.070 |
Why?
|
| Ovum | 1 | 2005 | 54 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2006 | 175 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 769 | 0.070 |
Why?
|
| Diagnosis, Differential | 7 | 2010 | 4744 | 0.070 |
Why?
|
| Propensity Score | 2 | 2020 | 750 | 0.070 |
Why?
|
| Phagocytosis | 3 | 2019 | 260 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 2 | 2004 | 545 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 3 | 2001 | 105 | 0.070 |
Why?
|
| Testis | 4 | 2006 | 717 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2005 | 118 | 0.070 |
Why?
|
| Brain | 6 | 2024 | 4113 | 0.070 |
Why?
|
| Mutation Rate | 2 | 2017 | 223 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2017 | 1863 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 143 | 0.070 |
Why?
|
| Pseudopodia | 1 | 2005 | 30 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 2 | 1996 | 151 | 0.070 |
Why?
|
| Lymph Node Excision | 3 | 2022 | 1959 | 0.070 |
Why?
|
| beta Catenin | 5 | 2013 | 688 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 1390 | 0.070 |
Why?
|
| Rhombencephalon | 1 | 2005 | 44 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 521 | 0.070 |
Why?
|
| Renin | 1 | 1985 | 92 | 0.070 |
Why?
|
| Estradiol | 2 | 2004 | 748 | 0.070 |
Why?
|
| Germ Cells | 1 | 2007 | 335 | 0.070 |
Why?
|
| Retina | 3 | 2001 | 532 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2012 | 821 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 161 | 0.060 |
Why?
|
| Pregnancy | 7 | 2016 | 7573 | 0.060 |
Why?
|
| Registries | 3 | 2018 | 2170 | 0.060 |
Why?
|
| Seizures | 1 | 2011 | 989 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2005 | 189 | 0.060 |
Why?
|
| Hepatic Artery | 2 | 1996 | 240 | 0.060 |
Why?
|
| Wnt1 Protein | 3 | 2000 | 103 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5319 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2022 | 256 | 0.060 |
Why?
|
| Placenta | 3 | 2015 | 516 | 0.060 |
Why?
|
| Polyethyleneimine | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 702 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 1070 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2004 | 588 | 0.060 |
Why?
|
| Mammary Glands, Animal | 2 | 2020 | 533 | 0.060 |
Why?
|
| CHO Cells | 3 | 1997 | 311 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 161 | 0.060 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2020 | 691 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 1 | 2004 | 37 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2024 | 585 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 33 | 0.060 |
Why?
|
| Mammography | 3 | 2019 | 1010 | 0.060 |
Why?
|
| Lactates | 1 | 2024 | 112 | 0.060 |
Why?
|
| Inhibins | 3 | 1992 | 128 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2007 | 829 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2004 | 32 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2008 | 406 | 0.060 |
Why?
|
| Angiography | 3 | 2001 | 360 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 1242 | 0.060 |
Why?
|
| Phenols | 1 | 2004 | 107 | 0.060 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2003 | 15 | 0.060 |
Why?
|
| Cricetinae | 3 | 1997 | 706 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2004 | 875 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 1 | 2004 | 175 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2004 | 214 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 4320 | 0.060 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2023 | 9 | 0.060 |
Why?
|
| Leucine Zippers | 1 | 2023 | 39 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1999 | 241 | 0.060 |
Why?
|
| Scleroderma, Systemic | 1 | 2004 | 134 | 0.060 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 25 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2006 | 297 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 365 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 42 | 0.060 |
Why?
|
| Weight Loss | 2 | 2018 | 627 | 0.060 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2006 | 362 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2007 | 1391 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 305 | 0.060 |
Why?
|
| Myelopoiesis | 1 | 2023 | 31 | 0.060 |
Why?
|
| Glypicans | 1 | 2003 | 51 | 0.060 |
Why?
|
| Fetus | 2 | 1997 | 601 | 0.060 |
Why?
|
| Collagen | 2 | 1997 | 752 | 0.060 |
Why?
|
| Therapeutic Index | 1 | 2022 | 1 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2001 | 562 | 0.060 |
Why?
|
| Lymphoma, Follicular | 1 | 2008 | 587 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 4549 | 0.060 |
Why?
|
| Intestines | 2 | 2015 | 686 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2004 | 327 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 163 | 0.050 |
Why?
|
| Biopsy, Needle | 3 | 2011 | 1363 | 0.050 |
Why?
|
| Lymph Nodes | 3 | 2022 | 2967 | 0.050 |
Why?
|
| Everolimus | 2 | 2019 | 415 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2015 | 231 | 0.050 |
Why?
|
| Animal Population Groups | 1 | 2002 | 2 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 223 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 35 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2004 | 252 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6100 | 0.050 |
Why?
|
| Neoplasm Transplantation | 4 | 2013 | 1519 | 0.050 |
Why?
|
| Alternative Splicing | 3 | 2001 | 584 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2003 | 303 | 0.050 |
Why?
|
| Stromal Cells | 2 | 2015 | 825 | 0.050 |
Why?
|
| Aldehyde Reductase | 2 | 1994 | 60 | 0.050 |
Why?
|
| Genes | 2 | 1997 | 491 | 0.050 |
Why?
|
| Neuropeptide Y | 2 | 2001 | 47 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 1081 | 0.050 |
Why?
|
| Eye Proteins | 2 | 2001 | 269 | 0.050 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2022 | 38 | 0.050 |
Why?
|
| Hormone Antagonists | 1 | 2002 | 101 | 0.050 |
Why?
|
| Yeasts | 1 | 2002 | 74 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 1648 | 0.050 |
Why?
|
| Cholangiography | 2 | 1999 | 36 | 0.050 |
Why?
|
| Plants | 1 | 2002 | 62 | 0.050 |
Why?
|
| Software | 3 | 2018 | 1321 | 0.050 |
Why?
|
| Aging | 3 | 1997 | 1582 | 0.050 |
Why?
|
| Calcimycin | 1 | 2001 | 48 | 0.050 |
Why?
|
| RNA | 3 | 2022 | 1013 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 1999 | 798 | 0.050 |
Why?
|
| Phospholipases A2 | 1 | 2001 | 43 | 0.050 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 65 | 0.050 |
Why?
|
| Cystadenoma, Serous | 1 | 2001 | 29 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2001 | 57 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 1303 | 0.050 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2012 | 2370 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2018 | 239 | 0.050 |
Why?
|
| Motilin | 1 | 2001 | 3 | 0.050 |
Why?
|
| Helminth Proteins | 1 | 2002 | 107 | 0.050 |
Why?
|
| Citrulline | 1 | 2022 | 108 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2007 | 354 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 67 | 0.050 |
Why?
|
| Urochordata | 2 | 1997 | 4 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 245 | 0.050 |
Why?
|
| Macromolecular Substances | 4 | 1997 | 293 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2001 | 842 | 0.050 |
Why?
|
| Lymphoma | 2 | 2000 | 1467 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 118 | 0.050 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2021 | 59 | 0.050 |
Why?
|
| Triiodothyronine | 1 | 2001 | 77 | 0.050 |
Why?
|
| Ligation | 2 | 1999 | 193 | 0.050 |
Why?
|
| Salmonella Infections | 1 | 2001 | 40 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 184 | 0.050 |
Why?
|
| Hyaluronic Acid | 2 | 1997 | 168 | 0.050 |
Why?
|
| Appetite | 1 | 2001 | 73 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 716 | 0.050 |
Why?
|
| Elasticity | 2 | 2018 | 156 | 0.050 |
Why?
|
| Clitoris | 1 | 2000 | 7 | 0.050 |
Why?
|
| Kinetics | 3 | 1999 | 2049 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2021 | 82 | 0.050 |
Why?
|
| Metaplasia | 1 | 2022 | 383 | 0.050 |
Why?
|
| Pancreatic Ducts | 1 | 2001 | 122 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 216 | 0.050 |
Why?
|
| Enteritis | 1 | 2001 | 65 | 0.050 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2002 | 342 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2001 | 165 | 0.050 |
Why?
|
| Organizers, Embryonic | 1 | 2000 | 8 | 0.050 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2000 | 23 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 201 | 0.050 |
Why?
|
| Brachytherapy | 1 | 2007 | 977 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2001 | 334 | 0.050 |
Why?
|
| Lithotripsy | 2 | 1999 | 21 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2001 | 75 | 0.050 |
Why?
|
| Cholecystectomy | 1 | 2001 | 107 | 0.050 |
Why?
|
| Anthelmintics | 2 | 2013 | 69 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2006 | 1335 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2000 | 96 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2000 | 749 | 0.050 |
Why?
|
| Bevacizumab | 2 | 2016 | 938 | 0.050 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 168 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2000 | 220 | 0.050 |
Why?
|
| HLA-DQ Antigens | 1 | 2000 | 58 | 0.050 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 37 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 276 | 0.050 |
Why?
|
| Syndrome | 1 | 2003 | 1351 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2020 | 84 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2000 | 173 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 5687 | 0.040 |
Why?
|
| Clone Cells | 1 | 2021 | 555 | 0.040 |
Why?
|
| Genome | 1 | 2003 | 672 | 0.040 |
Why?
|
| Nickel | 1 | 1999 | 44 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2007 | 1833 | 0.040 |
Why?
|
| Egg Proteins | 1 | 1999 | 66 | 0.040 |
Why?
|
| Histocompatibility | 1 | 2000 | 168 | 0.040 |
Why?
|
| Camptothecin | 1 | 2022 | 517 | 0.040 |
Why?
|
| Penis | 1 | 2000 | 123 | 0.040 |
Why?
|
| Methotrexate | 2 | 2000 | 999 | 0.040 |
Why?
|
| Sphincter of Oddi | 1 | 1999 | 5 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 2005 | 264 | 0.040 |
Why?
|
| Gastroscopes | 1 | 1999 | 10 | 0.040 |
Why?
|
| Activin Receptors, Type II | 1 | 1999 | 38 | 0.040 |
Why?
|
| Centrifugation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Protein Precursors | 2 | 1992 | 240 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 181 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 1999 | 77 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 1999 | 112 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2022 | 575 | 0.040 |
Why?
|
| Otx Transcription Factors | 1 | 1999 | 22 | 0.040 |
Why?
|
| Endoscopes | 1 | 1999 | 43 | 0.040 |
Why?
|
| Activin Receptors | 1 | 1998 | 19 | 0.040 |
Why?
|
| Drosophila melanogaster | 3 | 2011 | 829 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2020 | 129 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 1996 | 104 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 2 | 2011 | 1350 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2021 | 519 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1999 | 542 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2021 | 429 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 211 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 4143 | 0.040 |
Why?
|
| Risk | 2 | 2015 | 1972 | 0.040 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1998 | 37 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2000 | 266 | 0.040 |
Why?
|
| Gallbladder Neoplasms | 1 | 2001 | 245 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 471 | 0.040 |
Why?
|
| Actomyosin | 1 | 2018 | 11 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 3 | 2016 | 1121 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 182 | 0.040 |
Why?
|
| Chemokines | 1 | 2020 | 314 | 0.040 |
Why?
|
| Insect Hormones | 2 | 1995 | 15 | 0.040 |
Why?
|
| Time-Lapse Imaging | 1 | 2018 | 18 | 0.040 |
Why?
|
| Rabbits | 2 | 1997 | 957 | 0.040 |
Why?
|
| Energy Transfer | 1 | 2018 | 35 | 0.040 |
Why?
|
| Portography | 1 | 1997 | 8 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2020 | 285 | 0.040 |
Why?
|
| Species Specificity | 2 | 2016 | 777 | 0.040 |
Why?
|
| Blastomeres | 2 | 1994 | 24 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 1998 | 35 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gangliosides | 1 | 2018 | 95 | 0.040 |
Why?
|
| Bile Duct Diseases | 1 | 1998 | 45 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 149 | 0.040 |
Why?
|
| Stomach | 1 | 2001 | 387 | 0.040 |
Why?
|
| Duodenal Neoplasms | 1 | 1998 | 138 | 0.040 |
Why?
|
| Cecal Diseases | 1 | 1997 | 13 | 0.040 |
Why?
|
| Bombyx | 1 | 1997 | 4 | 0.040 |
Why?
|
| Technetium | 1 | 2017 | 77 | 0.040 |
Why?
|
| Ileal Diseases | 1 | 1997 | 27 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2000 | 1082 | 0.040 |
Why?
|
| Prazosin | 1 | 1997 | 22 | 0.040 |
Why?
|
| Mastectomy, Simple | 1 | 2017 | 58 | 0.040 |
Why?
|
| Ketones | 1 | 2017 | 54 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 1997 | 19 | 0.040 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2017 | 26 | 0.040 |
Why?
|
| Indolizines | 1 | 2017 | 45 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2017 | 2307 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 119 | 0.040 |
Why?
|
| Rosaniline Dyes | 1 | 2017 | 108 | 0.040 |
Why?
|
| Furans | 1 | 2017 | 104 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 1997 | 33 | 0.040 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1998 | 85 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 462 | 0.040 |
Why?
|
| Diarrhea | 1 | 2001 | 686 | 0.040 |
Why?
|
| Ions | 1 | 1997 | 53 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 2017 | 52 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2001 | 943 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1997 | 300 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 1994 | 28 | 0.040 |
Why?
|
| Ulcer | 1 | 1997 | 78 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1997 | 67 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2017 | 275 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2017 | 63 | 0.040 |
Why?
|
| Solubility | 1 | 1997 | 242 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2017 | 114 | 0.040 |
Why?
|
| Mannitol | 1 | 1997 | 54 | 0.040 |
Why?
|
| Acclimatization | 1 | 1997 | 42 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2002 | 941 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 1997 | 71 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 57 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1997 | 116 | 0.040 |
Why?
|
| Blood Cells | 1 | 2017 | 127 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1997 | 80 | 0.040 |
Why?
|
| Tetraploidy | 1 | 2016 | 5 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2017 | 106 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2017 | 157 | 0.040 |
Why?
|
| Mosaicism | 2 | 2017 | 272 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 1998 | 202 | 0.040 |
Why?
|
| Genetic Speciation | 1 | 2016 | 28 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2017 | 79 | 0.040 |
Why?
|
| Gels | 1 | 1997 | 105 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 1997 | 75 | 0.040 |
Why?
|
| Gastroscopy | 2 | 2012 | 134 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2016 | 25 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 854 | 0.040 |
Why?
|
| Catheterization | 1 | 1999 | 410 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1489 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 1073 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 344 | 0.040 |
Why?
|
| Diploidy | 1 | 2016 | 114 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 1997 | 131 | 0.040 |
Why?
|
| Light | 1 | 1997 | 245 | 0.040 |
Why?
|
| Gallstones | 1 | 1996 | 62 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 149 | 0.030 |
Why?
|
| Cattle | 2 | 1997 | 783 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2016 | 69 | 0.030 |
Why?
|
| Mitosis | 2 | 2012 | 615 | 0.030 |
Why?
|
| Crosses, Genetic | 3 | 2004 | 241 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1997 | 475 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 634 | 0.030 |
Why?
|
| Tyrosine | 2 | 2016 | 498 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 1996 | 39 | 0.030 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1996 | 68 | 0.030 |
Why?
|
| Bilirubin | 1 | 1997 | 221 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 392 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 703 | 0.030 |
Why?
|
| Body Fluids | 1 | 1997 | 125 | 0.030 |
Why?
|
| Uveitis | 1 | 1996 | 33 | 0.030 |
Why?
|
| Pancreas | 2 | 1996 | 718 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1997 | 587 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 554 | 0.030 |
Why?
|
| Recombinational DNA Repair | 1 | 2016 | 79 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 905 | 0.030 |
Why?
|
| Ion Channels | 1 | 1997 | 212 | 0.030 |
Why?
|
| Etoposide | 2 | 2000 | 870 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2016 | 185 | 0.030 |
Why?
|
| Gastrectomy | 1 | 1998 | 451 | 0.030 |
Why?
|
| Machine Learning | 1 | 2018 | 319 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2015 | 10 | 0.030 |
Why?
|
| Wings, Animal | 3 | 2000 | 62 | 0.030 |
Why?
|
| Muridae | 1 | 1995 | 21 | 0.030 |
Why?
|
| Acute Disease | 4 | 2002 | 2422 | 0.030 |
Why?
|
| Hemangioma | 1 | 1997 | 154 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 626 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2017 | 314 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 198 | 0.030 |
Why?
|
| Lymphatic System | 1 | 2015 | 64 | 0.030 |
Why?
|
| Organ Size | 1 | 1997 | 690 | 0.030 |
Why?
|
| Insulin | 2 | 2008 | 1454 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 4654 | 0.030 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2016 | 1442 | 0.030 |
Why?
|
| Azacitidine | 1 | 2001 | 1149 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1996 | 246 | 0.030 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 1984 | 13 | 0.030 |
Why?
|
| Lung | 1 | 2006 | 3151 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 1299 | 0.030 |
Why?
|
| Bone Marrow | 2 | 1997 | 2358 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 1998 | 622 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2017 | 308 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 803 | 0.030 |
Why?
|
| Ganglia | 1 | 1994 | 20 | 0.030 |
Why?
|
| Arteries | 1 | 1996 | 274 | 0.030 |
Why?
|
| Meat | 1 | 2015 | 87 | 0.030 |
Why?
|
| Cranial Nerves | 1 | 1994 | 20 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 348 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 260 | 0.030 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 1046 | 0.030 |
Why?
|
| Imidazolidines | 1 | 1994 | 8 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 1997 | 369 | 0.030 |
Why?
|
| DNA Replication | 2 | 2016 | 744 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 586 | 0.030 |
Why?
|
| Ki-67 Antigen | 2 | 2010 | 666 | 0.030 |
Why?
|
| Chickens | 2 | 2006 | 523 | 0.030 |
Why?
|
| Aldehydes | 1 | 1994 | 44 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1992 | 157 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2007 | 177 | 0.030 |
Why?
|
| Chick Embryo | 3 | 2001 | 242 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 756 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2016 | 239 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2014 | 85 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 46 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Hypoxia | 1 | 1997 | 443 | 0.030 |
Why?
|
| NADP | 1 | 1994 | 96 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 945 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 621 | 0.030 |
Why?
|
| Forecasting | 2 | 2011 | 694 | 0.030 |
Why?
|
| 3T3 Cells | 3 | 2000 | 355 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 58 | 0.030 |
Why?
|
| Adenoma | 1 | 1999 | 716 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2013 | 8 | 0.030 |
Why?
|
| Post-Synaptic Density | 1 | 2013 | 13 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1225 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 238 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 672 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 4 | 1999 | 621 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1997 | 584 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 223 | 0.030 |
Why?
|
| Immunochemistry | 1 | 1993 | 61 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1994 | 229 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2016 | 519 | 0.030 |
Why?
|
| Microdissection | 1 | 2013 | 86 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 69 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 860 | 0.030 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1992 | 33 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2013 | 106 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 289 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 132 | 0.030 |
Why?
|
| Melanins | 1 | 1992 | 50 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 677 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 237 | 0.030 |
Why?
|
| Polar Bodies | 1 | 2012 | 1 | 0.030 |
Why?
|
| Parthenogenesis | 1 | 2012 | 2 | 0.030 |
Why?
|
| In Vitro Oocyte Maturation Techniques | 1 | 2012 | 3 | 0.030 |
Why?
|
| Thoracic Wall | 1 | 2015 | 183 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2001 | 715 | 0.030 |
Why?
|
| Oncogenes | 1 | 2016 | 673 | 0.030 |
Why?
|
| Sirolimus | 2 | 2010 | 814 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 1183 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 1998 | 1656 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 103 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1993 | 137 | 0.030 |
Why?
|
| Leukemia | 1 | 2001 | 1635 | 0.030 |
Why?
|
| Granulosa Cells | 2 | 1999 | 146 | 0.030 |
Why?
|
| Residual Volume | 1 | 2012 | 11 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 2063 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 256 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1993 | 1258 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 752 | 0.030 |
Why?
|
| Amphibians | 1 | 2011 | 7 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2015 | 235 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2012 | 188 | 0.030 |
Why?
|
| Genes, Duplicate | 1 | 2011 | 21 | 0.030 |
Why?
|
| Liposomes | 2 | 2001 | 684 | 0.030 |
Why?
|
| Heterozygote | 2 | 2011 | 1020 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2009 | 1385 | 0.030 |
Why?
|
| Morpholinos | 1 | 2011 | 15 | 0.030 |
Why?
|
| Catalase | 1 | 2012 | 70 | 0.030 |
Why?
|
| POU Domain Factors | 1 | 2011 | 11 | 0.030 |
Why?
|
| Microfluidics | 1 | 2012 | 33 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 467 | 0.030 |
Why?
|
| Lymphatic Irradiation | 1 | 2012 | 133 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2006 | 829 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2011 | 42 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 650 | 0.030 |
Why?
|
| Proteolysis | 1 | 2013 | 370 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 1546 | 0.030 |
Why?
|
| Meiosis | 1 | 2012 | 166 | 0.030 |
Why?
|
| Ejaculation | 1 | 1991 | 24 | 0.020 |
Why?
|
| Circular Dichroism | 3 | 2000 | 113 | 0.020 |
Why?
|
| Blood Donors | 1 | 2012 | 164 | 0.020 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2011 | 28 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 551 | 0.020 |
Why?
|
| Receptors, Notch | 2 | 2007 | 383 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 217 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2006 | 2390 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 306 | 0.020 |
Why?
|
| Extremities | 2 | 2005 | 303 | 0.020 |
Why?
|
| Anxiety | 1 | 1998 | 1179 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 611 | 0.020 |
Why?
|
| Dasatinib | 1 | 2014 | 862 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 74 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2002 | 63 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 202 | 0.020 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2010 | 46 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2012 | 291 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Data Collection | 1 | 2013 | 620 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2010 | 65 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 2001 | 241 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 392 | 0.020 |
Why?
|
| Filgrastim | 2 | 2000 | 191 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 709 | 0.020 |
Why?
|
| Salvage Therapy | 2 | 2012 | 2054 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 2218 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 1989 | 21 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 107 | 0.020 |
Why?
|
| Axin Protein | 2 | 1999 | 27 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2009 | 110 | 0.020 |
Why?
|
| Armadillo Domain Proteins | 2 | 1999 | 21 | 0.020 |
Why?
|
| Child | 5 | 2013 | 29154 | 0.020 |
Why?
|
| Radiation-Protective Agents | 1 | 2010 | 128 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2010 | 123 | 0.020 |
Why?
|
| Models, Structural | 1 | 1989 | 103 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 891 | 0.020 |
Why?
|
| Calcium Carbonate | 1 | 1989 | 28 | 0.020 |
Why?
|
| Oocytes | 1 | 1992 | 414 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 238 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 1999 | 98 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 2083 | 0.020 |
Why?
|
| Osteocalcin | 1 | 1989 | 87 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 518 | 0.020 |
Why?
|
| Vincristine | 1 | 1993 | 1511 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Butylene Glycols | 1 | 2008 | 1 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Antibodies | 1 | 1992 | 838 | 0.020 |
Why?
|
| Brain Chemistry | 2 | 1986 | 145 | 0.020 |
Why?
|
| Oxygen | 1 | 1992 | 754 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 77 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2009 | 242 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1984 | 30 | 0.020 |
Why?
|
| Adrenal Glands | 2 | 1986 | 122 | 0.020 |
Why?
|
| Axoneme | 1 | 2007 | 8 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 1283 | 0.020 |
Why?
|
| Ultrasonography, Mammary | 1 | 2010 | 380 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 205 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 980 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 739 | 0.020 |
Why?
|
| Nodal Protein | 1 | 2007 | 21 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2010 | 576 | 0.020 |
Why?
|
| Neutropenia | 1 | 2012 | 968 | 0.020 |
Why?
|
| Glucosides | 1 | 2008 | 64 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2008 | 209 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2010 | 351 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2013 | 16273 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 598 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2010 | 627 | 0.020 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2007 | 123 | 0.020 |
Why?
|
| Thiabendazole | 1 | 2006 | 9 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1991 | 529 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1997 | 1618 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 1986 | 19 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 229 | 0.020 |
Why?
|
| Ivermectin | 1 | 2006 | 20 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1989 | 241 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2006 | 97 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 125 | 0.020 |
Why?
|
| Aromatase | 1 | 1986 | 56 | 0.020 |
Why?
|
| Endocytosis | 1 | 2007 | 225 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2007 | 135 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1986 | 143 | 0.020 |
Why?
|
| Radiometry | 1 | 2012 | 980 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2010 | 651 | 0.020 |
Why?
|
| Leptin | 1 | 2008 | 295 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1986 | 276 | 0.020 |
Why?
|
| Sheep | 2 | 1996 | 258 | 0.020 |
Why?
|
| Adipocytes | 1 | 2008 | 305 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1986 | 237 | 0.020 |
Why?
|
| Genetic Code | 1 | 1985 | 32 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1985 | 66 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1985 | 34 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1986 | 150 | 0.020 |
Why?
|
| Amino Acids | 3 | 2000 | 728 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 864 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1986 | 347 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1986 | 327 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 603 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 1985 | 171 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 2992 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 82 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 44 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2004 | 39 | 0.020 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2004 | 3 | 0.020 |
Why?
|
| Hematopoiesis | 2 | 1998 | 560 | 0.020 |
Why?
|
| Aphidicolin | 1 | 2004 | 30 | 0.020 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2004 | 19 | 0.020 |
Why?
|
| Cdc20 Proteins | 1 | 2004 | 25 | 0.020 |
Why?
|
| Retinoids | 1 | 2005 | 164 | 0.020 |
Why?
|
| Cdh1 Proteins | 1 | 2004 | 18 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 85 | 0.010 |
Why?
|
| Endoscopy | 2 | 1999 | 479 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 129 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2007 | 745 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2004 | 314 | 0.010 |
Why?
|
| X-Rays | 1 | 2004 | 146 | 0.010 |
Why?
|
| Cytarabine | 2 | 2000 | 1973 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2007 | 611 | 0.010 |
Why?
|
| G2 Phase | 1 | 2004 | 206 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 1271 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2003 | 27 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 85 | 0.010 |
Why?
|
| Steroids | 1 | 2005 | 356 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2015 | 5542 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2003 | 127 | 0.010 |
Why?
|
| Rituximab | 1 | 2008 | 1528 | 0.010 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1986 | 1021 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 1818 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2003 | 205 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 188 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2003 | 137 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 123 | 0.010 |
Why?
|
| Tretinoin | 1 | 2005 | 623 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 1294 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 456 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 644 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2005 | 448 | 0.010 |
Why?
|
| Esophagectomy | 1 | 2007 | 911 | 0.010 |
Why?
|
| Aqueous Humor | 2 | 1996 | 29 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2003 | 184 | 0.010 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2001 | 86 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1995 | 82 | 0.010 |
Why?
|
| Microinjections | 1 | 2001 | 96 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 2001 | 56 | 0.010 |
Why?
|
| Salmonella enterica | 1 | 2001 | 12 | 0.010 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2001 | 10 | 0.010 |
Why?
|
| Receptors, Neuropeptide | 1 | 2001 | 27 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 114 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1997 | 548 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2001 | 43 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2001 | 104 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1986 | 1245 | 0.010 |
Why?
|
| Swine | 3 | 1992 | 1541 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2001 | 222 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2001 | 63 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2001 | 137 | 0.010 |
Why?
|
| CA-19-9 Antigen | 1 | 2001 | 144 | 0.010 |
Why?
|
| Electroporation | 1 | 2001 | 126 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2001 | 94 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Ghrelin | 1 | 2001 | 79 | 0.010 |
Why?
|
| Decision Trees | 1 | 2001 | 178 | 0.010 |
Why?
|
| Injections | 1 | 2001 | 285 | 0.010 |
Why?
|
| Mesna | 1 | 2000 | 65 | 0.010 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2000 | 26 | 0.010 |
Why?
|
| Genitalia | 1 | 2000 | 46 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 294 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2000 | 34 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 445 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2007 | 882 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 333 | 0.010 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2000 | 105 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2000 | 119 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2000 | 67 | 0.010 |
Why?
|
| Smad8 Protein | 1 | 1999 | 9 | 0.010 |
Why?
|
| Thorax | 1 | 2001 | 213 | 0.010 |
Why?
|
| Nerve Crush | 1 | 1999 | 9 | 0.010 |
Why?
|
| Wallerian Degeneration | 1 | 1999 | 9 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2000 | 96 | 0.010 |
Why?
|
| Urethra | 1 | 2000 | 144 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 2000 | 228 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 109 | 0.010 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 1999 | 37 | 0.010 |
Why?
|
| Ifosfamide | 1 | 2000 | 344 | 0.010 |
Why?
|
| Infant | 2 | 2013 | 13310 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 461 | 0.010 |
Why?
|
| Podophyllotoxin | 1 | 1999 | 63 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 401 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 189 | 0.010 |
Why?
|
| Virus Activation | 1 | 2001 | 228 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 336 | 0.010 |
Why?
|
| Mitochondria | 1 | 2006 | 1282 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 93 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1998 | 59 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2001 | 255 | 0.010 |
Why?
|
| Adenosine | 1 | 2001 | 289 | 0.010 |
Why?
|
| Genes, Insect | 1 | 1999 | 131 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 1062 | 0.010 |
Why?
|
| Zona Fasciculata | 1 | 1998 | 2 | 0.010 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 1999 | 119 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1999 | 149 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 76 | 0.010 |
Why?
|
| Idarubicin | 1 | 2000 | 446 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1998 | 82 | 0.010 |
Why?
|
| Zygote | 1 | 1997 | 36 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1997 | 28 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1998 | 162 | 0.010 |
Why?
|
| Stomatitis, Aphthous | 1 | 1997 | 7 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 97 | 0.010 |
Why?
|
| Co-Repressor Proteins | 1 | 1998 | 122 | 0.010 |
Why?
|
| Coturnix | 1 | 1997 | 10 | 0.010 |
Why?
|
| Axons | 1 | 2000 | 403 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 334 | 0.010 |
Why?
|
| PAX3 Transcription Factor | 1 | 1997 | 37 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 71 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1999 | 286 | 0.010 |
Why?
|
| Free Radicals | 1 | 1997 | 62 | 0.010 |
Why?
|
| Ducks | 1 | 1996 | 7 | 0.010 |
Why?
|
| Busulfan | 1 | 2001 | 764 | 0.010 |
Why?
|
| Chimera | 1 | 1997 | 145 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1998 | 310 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 1997 | 147 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2001 | 652 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 1997 | 134 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1997 | 153 | 0.010 |
Why?
|
| Cystic Duct | 1 | 1996 | 10 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1999 | 546 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1996 | 57 | 0.010 |
Why?
|
| Lipoma | 1 | 1997 | 89 | 0.010 |
Why?
|
| Transforming Growth Factors | 2 | 1986 | 40 | 0.010 |
Why?
|
| GATA2 Transcription Factor | 1 | 1996 | 68 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 1999 | 291 | 0.010 |
Why?
|
| Keratins | 1 | 1997 | 330 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 1996 | 35 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1996 | 65 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1996 | 80 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1996 | 74 | 0.010 |
Why?
|
| Endotoxins | 1 | 1996 | 96 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1996 | 91 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 120 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1997 | 197 | 0.010 |
Why?
|
| Spodoptera | 1 | 1995 | 63 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1996 | 166 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1995 | 86 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2001 | 1819 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1995 | 200 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 1204 | 0.010 |
Why?
|
| Necrosis | 1 | 1996 | 580 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 117 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1999 | 613 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 266 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2001 | 992 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 1732 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1995 | 239 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2001 | 808 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1994 | 3 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1994 | 7 | 0.010 |
Why?
|
| Quercetin | 1 | 1994 | 16 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1994 | 71 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1994 | 130 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1996 | 132 | 0.010 |
Why?
|
| Deuterium | 1 | 1994 | 111 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 423 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1996 | 886 | 0.010 |
Why?
|
| Biological Assay | 1 | 1995 | 177 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 1682 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1994 | 83 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1998 | 935 | 0.010 |
Why?
|
| Homozygote | 1 | 1995 | 717 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 432 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1996 | 558 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1992 | 8 | 0.010 |
Why?
|
| Cysteine | 1 | 1994 | 214 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1992 | 82 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 1992 | 59 | 0.010 |
Why?
|
| Gestational Age | 1 | 1996 | 1069 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1996 | 1338 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1992 | 118 | 0.010 |
Why?
|
| Exons | 1 | 1995 | 1328 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1992 | 717 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1991 | 145 | 0.010 |
Why?
|
| Skin | 1 | 1996 | 1259 | 0.010 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 1989 | 3 | 0.010 |
Why?
|
| Contrast Media | 1 | 1997 | 1472 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1991 | 159 | 0.010 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1989 | 12 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 2483 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1989 | 105 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1996 | 1203 | 0.010 |
Why?
|
| Length of Stay | 1 | 1996 | 1900 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1989 | 209 | 0.010 |
Why?
|
| Tegafur | 1 | 1989 | 50 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1989 | 139 | 0.010 |
Why?
|
| Uracil | 1 | 1989 | 64 | 0.010 |
Why?
|
| DNA Polymerase II | 1 | 1989 | 59 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1989 | 281 | 0.010 |
Why?
|
| Karyotyping | 1 | 1989 | 1022 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1996 | 1225 | 0.000 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1986 | 15 | 0.000 |
Why?
|
| Sulfoglycosphingolipids | 1 | 1986 | 11 | 0.000 |
Why?
|
| Androstenedione | 1 | 1986 | 18 | 0.000 |
Why?
|
| Chromosome Banding | 1 | 1986 | 256 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 410 | 0.000 |
Why?
|
| Corpus Luteum | 1 | 1986 | 32 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1986 | 122 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1986 | 295 | 0.000 |
Why?
|
| Trabecular Meshwork | 1 | 1985 | 12 | 0.000 |
Why?
|
| Macaca fascicularis | 1 | 1985 | 137 | 0.000 |
Why?
|
| Chemistry | 1 | 1984 | 99 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 137 | 0.000 |
Why?
|
| Osteosarcoma | 1 | 1992 | 929 | 0.000 |
Why?
|
| Intraocular Pressure | 1 | 1985 | 146 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1984 | 226 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1988 | 1234 | 0.000 |
Why?
|
| Estrogens | 1 | 1986 | 751 | 0.000 |
Why?
|
| Cornea | 1 | 1985 | 638 | 0.000 |
Why?
|